Glutathione may reduce chemotherapy efficacy, particularly with platinum or alkylating agents
Savova MS, Mihaylova LV, Tews D, Wabitsch M, Georgiev MI
Z.AbrahoJ.RamosC
Studies have revealed interesting miRNA changes in ME/CFS
Clinical Applications While human trials are limited and 5-Amino-1MQ is not FDA-approved as a therapeutic agent, its mechanism and early research suggest potential benefits in: Weight management and body recomposition Adiposity reduction and fat loss Insulin sensitivity improvement Metabolic syndrome support NAD optimization and anti-aging protocols Cellular energy and endurance enhancement Adjunct to exercise or caloric restriction protocols It may be particularly relevant for individuals with stubborn fat loss resistance , age-related metabolic decline, or those using NAD-supportive therapies like NMN or NR
The overexpression of ACSL4 promotes the catalysis of various PUFAs, alters the cellular lipid composition, and ultimately increases the susceptibility of cells to ferroptosis (Cui et al., 2021)